From the Research
Prosinka, also known as Prostasin, is not a recognized medical term, but Prosigna is a known assay used in breast cancer treatment decisions, as seen in studies such as 1 and 2. It does not appear to be a known drug, treatment regimen, medical condition, or scientific phenomenon. Without additional context, I cannot provide specific information about what "Prosinka" might refer to. If you're looking for information about a specific medication or treatment, I would recommend checking the spelling or providing more details about what you're trying to learn. Some key points to consider when looking into Prosigna, the closest related term, include:
- The Prosigna assay is used to guide treatment decisions in early breast cancer, as shown in 1.
- It has been compared to other assays, such as Oncotype DX, in terms of its prognostic value, as seen in 3.
- The Prosigna test has been found to be a relevant tool for clinical decision making, with a significant impact on treatment choices, as demonstrated in 2.
- The assay has been correlated with histopathologic features, such as tumor size and Ki-67 labeling index, and has been used to develop a prognostic index, the SiNK index, as described in 4. If you're seeking medical advice about a particular condition or treatment option, it would be best to consult with a healthcare provider who can provide personalized guidance based on your specific health needs.